COTELLIC® (cobimetinib) + ZELBORAF® (vemurafenib) Objective Response Rate
Efficacy | BALVERSA® (erdafitinib) HCP
Updated Data for Indoximod Plus KEYTRUDA® (pembrolizumab) Demonstrate Improvement of Response Rate for Patients with Advanced Melanoma | Business Wire
The overall response rate | Download Table
Confirmed ORR | ENHERTU® (fam-trastuzumab deruxtecan-nxki)
Study 1104 Overall Response Rate: R/R MCL | IMBRUVICA® (ibrutinib) HCP
Forest plot of the comparison of overall response rate (ORR).
BRAFTOVI + cetuximab | Overall Response Rate | ORR | BEACON CRC
Overall response rate | Download Table
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Efficacy I PLUVICTO
ORR (Objective Response Rate) and related statistics – Part 1
Efficacy endpoints in Oncology
ORR (Objective Response Rate) and related statistics – Part 1
Confirmed ORR | ENHERTU® (fam-trastuzumab deruxtecan-nxki)
ODOMZO® (sonidegib) | Efficacy Data
Response rates Overall response rate and depth of response according to... | Download Scientific Diagram
Durable Response Rate
Pecoma Clinical Trial Efficacy Data | FYARRO | HCP Site
Visualization of efficacy endpoints in oncology clinical trials
Simplifying the Derivation of Best Overall Response per RECIST 1.1 and iRECIST in Solid Tumor Clinical Studies
Five-Year Overall Survival for Patients With Advanced Non‒Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study | Journal of Clinical Oncology
TECARTUS® Efficacy - Response Data for R/R MCL
MZL Efficacy Data: Overall Response Rates | IMBRUVICA® | HCP
Efficacy Data | KYMRIAH® (tisagenlecleucel) for DLBCL | HCP
Positive plasma cotinine during platinum-based chemotherapy is associated with poor response rate in advanced non-small cell lung cancer patients | PLOS ONE
Durable Response Rate
ORR (Objective Response Rate) and related statistics – Part 1
Durable Responses Are Observed With Cemiplimab in mBCC
